abstract |
The present invention is concerned with the use of R(-)-2,4-diamino-5-(2,3-dichlorophenyl)-6-fluoromethyl pyrimidine of formula (I), or pharmaceutically acceptable salts, solvates or prodrugs thereof, either as monotherapy or in combination with another therapeutic agent, for the treatment of psychotic disorders: |